Stock Price
36.39
Daily Change
0.09 0.25%
Monthly
-12.04%
Yearly
-27.37%
Q2 Forecast
34.72

EPS Reference Time Actual Consensus Previous
2026-05-07 FY2026Q2 AM 0.52 0.56
2026-02-05 FY2026Q1 AM 0.49 0.45 0.51
2025-11-05 FY2025Q4 AM 0.68 0.71 0.67
2025-07-30 FY2025Q3 AM 0.64 0.58 0.52
2025-05-07 FY2025Q2 AM 0.56 0.56 0.55



Peers Price Chg Day Year Date
Avanos Medical 14.19 0.18 1.28% -2.27% Apr/01
Brookdale Senior Living 13.94 0.26 1.90% 130.79% Apr/01
Cencora 317.66 3.52 1.12% 13.65% Apr/01
Encompass Health 97.19 0.46 0.48% -4.79% Apr/01
Enovis 23.34 0.59 2.59% -36.88% Apr/01
GE HealthCare Technologies 71.98 0.80 1.12% -9.30% Apr/01
Pediatrix Medical Group 20.70 -0.69 -3.23% -3.59% Apr/01
Veradigm 4.56 -0.09 -1.94% 7.29% Apr/01
OPKO Health 358.50 0 0% -42.04% Apr/01
Siemens Healthineers 36.39 0.09 0.25% -27.37% Apr/01

Indexes Price Day Year Date
DE40 23299 618.85 2.73% 4.06% Apr/01

Siemens Healthineers AG traded at 36.39 this Wednesday April 1st, increasing 0.09 or 0.25 percent since the previous trading session. Looking back, over the last four weeks, Siemens Healthineers gained 12.04 percent. Over the last 12 months, its price fell by 27.37 percent. Looking ahead, we forecast Siemens Healthineers AG to be priced at 34.72 by the end of this quarter and at 31.76 in one year, according to Trading Economics global macro models projections and analysts expectations.

Siemens Healthineers AG is a Germany-based company. The Company is a global provider of healthcare products, solutions and services. It also provides clinical consulting services and training and service offerings. The Company’s segments include Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers a software solutions to support the reading and structured reporting of diagnostic images from different modalities. The Diagnostics segment offers to healthcare providers in the fields of general laboratory, specialty laboratory, and point-of-care diagnostics. The Varian segment offers a portfolio of cancer care technologies and services and support oncology departments in hospitals and clinics. The Advanced Therapies segment consists of integrated products, services and solutions used in the treatment of diseases across multiple clinical fields.